PROactive, Prospective Pioglitazone Clinical Trial in Macrovascular Events - PIONEER

Description:

The goal of the trial was to evaluate the effect on inflammatory biomarkers of arteriosclerosis of treatment with pioglitazone compared with glimepiride among patients with type II diabetes.